Gabelli & Co Investment Advisers’s Syneron Medical Ltd ELOS Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-97,775	Closed	-$1.07M	–	198
2017 Q2	$1.07M	Buy	+97,775	New	+$1.07M	0.12%	76

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Gabelli & Co Investment Advisers's ELOS Position: Q3 2017 in Review

Gabelli & Co Investment Advisers sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 97,775 shares — an estimated $1.07M sold.

Gabelli & Co Investment Advisers first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $1.07M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Gabelli & Co Investment Advisers reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 97,775 Syneron Medical Ltd shares in Q3 2017, an estimated $1.07M.
Gabelli & Co Investment Advisers first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Syneron Medical Ltd position peaked at $1.07M in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2017, filed 1 Nov 2017.